Through our expertise in performing and executing challenging chemistries, we offer an extensive and diverse range of research products which include novel building blocks, screening compounds as well as a variety of biochemicals and exclusive substituted fluoro aromatic compounds to help enhance and energise drug discovery programmes.

For further information on each category of compounds please click on the links below:

Top of page

Industry News

Entrants so far have come from Shire, Bayer, AbbVie, Eisai Europe, Novartis, GSK, MSD, Lundbeck, HFA Healthcare Products, Sandoz and...
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us